Gian Paolo Visentin

2.1k total citations
26 papers, 1.6k citations indexed

About

Gian Paolo Visentin is a scholar working on Hematology, Surgery and Emergency Medicine. According to data from OpenAlex, Gian Paolo Visentin has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 18 papers in Surgery and 8 papers in Emergency Medicine. Recurrent topics in Gian Paolo Visentin's work include Platelet Disorders and Treatments (18 papers), Heparin-Induced Thrombocytopenia and Thrombosis (18 papers) and Intramuscular injections and effects (8 papers). Gian Paolo Visentin is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Heparin-Induced Thrombocytopenia and Thrombosis (18 papers) and Intramuscular injections and effects (8 papers). Gian Paolo Visentin collaborates with scholars based in United States, Italy and South Korea. Gian Paolo Visentin's co-authors include Richard H. Aster, James G. Scott, Chao Yan Liu, Mohammad Malik, Jang Soo Suh, Seon Ho Lee, Sriram Neelamegham, Qi‐Hong Sun, Manuela Battaglia and Kannayakanahalli M. Dayananda and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Gian Paolo Visentin

26 papers receiving 1.5k citations

Peers

Countries citing papers authored by Gian Paolo Visentin

Since Specialization

Citations

This map shows the geographic impact of Gian Paolo Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gian Paolo Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gian Paolo Visentin more than expected).

Fields of papers citing papers by Gian Paolo Visentin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gian Paolo Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gian Paolo Visentin. The network helps show where Gian Paolo Visentin may publish in the future.

Co-authorship network of co-authors of Gian Paolo Visentin

This figure shows the co-authorship network connecting the top 25 collaborators of Gian Paolo Visentin. A scholar is included among the top collaborators of Gian Paolo Visentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gian Paolo Visentin. Gian Paolo Visentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	New platelet functional method for identification of pathogenic antibodies in HIT patients 2017 ·Platelets ·Maria Guarino, Isabella Massimi, Stefania Mardente, A. Lappa, (unknown), Gian Paolo Visentin, Fabio M. Pulcinelli	9
2	A novel homozygous missense ADAMTS13 mutation Y658C in a patient with recurrent thrombotic thrombocytopenic purpura. 2011 ·PubMed ·Seon Ho Lee, Jae Hoo Park, Sangkyu Park, Eun Hee Lee, (unknown), Gian Paolo Visentin, Tae Sung Park, Seung Hwan Oh, Sung‐Ryul Kim	2
3	Activation of cytotoxic T-cell receptor T lymphocytes in response to specific stimulation in myelodysplastic syndromes 2008 ·Haematologica ·Jean‐Jacques Kiladjian, Gian Paolo Visentin, (unknown), Sylvie Chevret, Virginie Éclache, Jérôme Stirnemann, J. H. Bourhis, Salem Chouaı̈b, Pierre Fenaux, Anne Caignard	30
4	Immune complexes formed following the binding of anti–platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion 2008 ·Blood ·(unknown), Gian Paolo Visentin, Kannayakanahalli M. Dayananda, Sriram Neelamegham	70
5	Drug-Induced Thrombocytopenia 2007 ·Hematology/Oncology Clinics of North America ·Gian Paolo Visentin, Chao Yan Liu	124
6	Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes 2006 ·Leukemia ·Jean‐Jacques Kiladjian, (unknown), (unknown), Thorsten Braun, Gian Paolo Visentin, J-H Bourhis, Pierre Fenaux, Salem Chouaı̈b, Anne Caignard	92
7	Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25− (Nonregulatory) T Cells 2005 ·The Journal of Immunology ·Chao Yan Liu, Manuela Battaglia, Seon Ho Lee, Qi‐Hong Sun, Richard H. Aster, Gian Paolo Visentin	105
8	A Spliced Variant of CXCR3 (CXCR3B) Is Differentially Expressed on CD4+CD25+ Regulatory vs. CD4+CD25− Non-Regulatory T Cells Exposed to Platelet Factor 4 (PF4). 2004 ·Blood ·Chao Yan Liu, (unknown), Qi‐Hong Sun, Gian Paolo Visentin	2
9	Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis 2001 ·Journal of Laboratory and Clinical Medicine ·Gian Paolo Visentin, (unknown), (unknown), (unknown), Richard H. Aster	107
10	Identification of T cells responding to a self-protein modified by an external agent 2001 ·Human Immunology ·(unknown), (unknown), Gian Paolo Visentin, Raffaele De Palma, Richard H. Aster, Jack Gorski	15
11	Inhibition of Human Umbilical Vein Endothelial Cell Proliferation by the CXC Chemokine, Platelet Factor 4 (PF4), Is Associated With Impaired Downregulation of p21Cip1/WAF1 1999 ·Blood ·(unknown), Nancy E. Kirschbaum, James A. Augustine, Richard H. Aster, Gian Paolo Visentin	6
12	Complexes of Heparin and Platelet Factor 4 Specifically Stimulate T Cells From Patients With Heparin-Induced Thrombocytopenia/Thrombosis 1999 ·Blood ·(unknown), Raffaele De Palma, Gian Paolo Visentin, Jack Gorski, Richard H. Aster	43
13	Inhibition of Human Umbilical Vein Endothelial Cell Proliferation by the CXC Chemokine, Platelet Factor 4 (PF4), Is Associated With Impaired Downregulation of p21Cip1/WAF1 1999 ·Blood ·(unknown), Nancy E. Kirschbaum, James A. Augustine, Richard H. Aster, Gian Paolo Visentin	64
14	Cell Surface Glycosaminoglycans Do Not Serve as Ligands for PECAM-1 1998 ·Journal of Biological Chemistry ·(unknown), Cathy Paddock, Gian Paolo Visentin, Mark M. Zukowski, William A. Müller, Peter J. Newman	26
15	A Recombinant Soluble Form of the Integrin IIbβ3 (GPIIb-IIIa) Assumes an Active, Ligand-Binding Conformation and Is Recognized by GPIIb-IIIa–Specific Monoclonal, Allo-, Auto-, and Drug-Dependent Platelet Antibodies 1998 ·Blood ·Julie A. Peterson, Gian Paolo Visentin, Peter J. Newman, Richard H. Aster	42
16	A Recombinant Soluble Form of the Integrin IIbβ3 (GPIIb-IIIa) Assumes an Active, Ligand-Binding Conformation and Is Recognized by GPIIb-IIIa–Specific Monoclonal, Allo-, Auto-, and Drug-Dependent Platelet Antibodies 1998 ·Blood ·Julie A. Peterson, Gian Paolo Visentin, Peter J. Newman, Richard H. Aster	2
17	Characterization of the humoral immune response in heparin-induced thrombocytopenia 1997 ·American Journal of Hematology ·Jang Soo Suh, Mohammad Malik, Richard H. Aster, Gian Paolo Visentin	96
18	Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes 1996 ·Journal of Laboratory and Clinical Medicine ·Gian Paolo Visentin, Mohammad Malik, (unknown), Richard H. Aster	140
19	Heparin-induced thrombocytopenia and thrombosis 1995 ·Current Opinion in Hematology ·Gian Paolo Visentin, Richard H. Aster	12
20	[Anti-tissue autoantibodies in malignant pulmonary neoplasms]. 1983 ·PubMed ·Amelia Ruffatti, Gian Paolo Visentin, C. GIORDANO, (unknown), (unknown), S Todesco	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact